Defining Fluoroquinolone Resistance-Mediating Mutations from Non-Resistance Polymorphisms in <i>Mycoplasma hominis</i> Topoisomerases.

Defining Fluoroquinolone Resistance-Mediating Mutations from Non-Resistance Polymorphisms in Mycoplasma hominis Topoisomerases.

Sharratt, Martin; Sands, Kirsty; Portal, Edward A R; Boostrom, Ian; Mondeja, Brian A; Rodríguez, Nadia M; Jones, Lucy C; Spiller, Owen B.

Afiliação

Sharratt M; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
Sands K; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
Portal EAR; Department of Zoology, Oxford University, Oxford OX1 3RE, UK.
Boostrom I; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
Mondeja BA; Bacteriology Reference Department, UK Health Security Agency, London NW9 5EQ, UK.
Rodríguez NM; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
Jones LC; Pedro Kourí Tropical Medicine Institute, Havana 11400, Cuba.
Spiller OB; Center for Advance Research of Cuba, Havana CP17100, Cuba.

Antibiotics (Basel) ; 10(11)2021 Nov 10.

Article em En | MEDLINE | ID: mdl-34827317